Moneycontrol PRO
HomeNewsOutperform

Outperform

Jump to
  • Outperforming stocks: What should you do with them now?

    Following the recent market rally, a number of shares have seen a sharp upmove, with some inching close to their 52-week highs.

  • Nifty likely to touch 8900 by end of this year: IDFC Sec

    Nifty likely to touch 8900 by end of this year: IDFC Sec

    L&T will outperform in the next on year or so, says Anish Damania, CEO and head, Institutional Equities, at IDFC Securities. As for ITC, there could be more impact, as the government looks to bring in more controls in the liquor and cigarette businesses.

  • Expect to outperform industry growth by 10%: Suprajit Engg

    Expect to outperform industry growth by 10%: Suprajit Engg

    Ajith Rai of Suprajit Engineering says while Q3 hasn‘t been as good as H1, he expects the company to outperform industry by atleast 5-10 percent in FY15.

  • CLSA ups Info Edge price target; retains outperform rating

    CLSA ups Info Edge price target; retains outperform rating

    Info Edge remains an attractive listed Indian internet play with a recovering economy buoying its core business and value surfacing from new businesses, feels CLSA

  • ONGC gains on broker upgrades

    ONGC gains on broker upgrades

    ONGC shares have lost 20 percent since mid-May on concerns a weakening rupee would make oil imports more expensive.

  • Is Dish TV a good contrarian bet post poor Q1 earnings?

    Is Dish TV a good contrarian bet post poor Q1 earnings?

    Three brokerage firms have given their contrarian views on Dish TV that announced disappointing Q1 numbers.

  • Credit Suisse upgrades Wipro ahead of Q2 earnings

    Credit Suisse upgrades Wipro ahead of Q2 earnings

    Shares in Wipro gain 2.4 percent to Rs 344.05 after Credit Suisse upgrades stock to 'outperform' from 'neutral' and raises target price to Rs 415 from Rs 385.

  • Cipla drug price cut not to hurt revenue much, say analysts

    Cipla drug price cut not to hurt revenue much, say analysts

    Cipla's shocking 75% price cut of three cancer drugs on Thursday is unlikely to have a major impact on its earnings, analysts say.

  • Infosys hit by slew of downgrades

    Infosys hit by slew of downgrades

    Infosys lost 0.3% to Rs 2,394.50, extending losses from a 13% plunge on Friday after a slew of analysts downgraded the stock following its lower-than-expected revenue growth outlook on Friday.

  • Credit Suisse downgrades TCS to 'neutral'

    Credit Suisse downgrades TCS to 'neutral'

    Credit Suisse downgraded Tata Consultancy Services to 'neutral' from 'outperform' on Monday, saying all positives were priced in.

  • CLSA downgrades Bajaj Auto to underperform

    CLSA downgrades Bajaj Auto to underperform

    CLSA downgraded motorcycle and three-wheeled motorised rickshaw maker Bajaj Auto to "underperform" from "outperform" on Wednesday, a note seen by Reuters showed.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347